Next-generation muscle-directed gene therapy by in silico vector design
Adeno-associated viral vectors (AAV) are being developed for gene therapy of skeletal muscle, but it is a challenge to achieve robust gene expression. Here, the authors identify muscle-specific cisregulatory elements that lead to a substantial increase in micro-dystrophin and follistatin expression,...
Enregistré dans:
Auteurs principaux: | S. Sarcar, W. Tulalamba, M. Y. Rincon, J. Tipanee, H. Q. Pham, H. Evens, D. Boon, E. Samara-Kuko, M. Keyaerts, M. Loperfido, E. Berardi, S. Jarmin, P. In’t Veld, G. Dickson, T. Lahoutte, M. Sampaolesi, P. De Bleser, T. VandenDriessche, M. K. Chuah |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c5d6b54327424a9fb828402310c7a87f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants
par: Jonas Weinmann, et autres
Publié: (2020) -
Atonal homolog 1 is a tumor suppressor gene.
par: Wouter Bossuyt, et autres
Publié: (2009) -
In silico pharmacology
Publié: (2013) -
In silico biology
Publié: (1998) -
In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism
par: Valery M. Dembitsky
Publié: (2021)